Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2005
12/01/2005US20050267142 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
12/01/2005US20050267139 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267138 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267115 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence
12/01/2005US20050267113 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; interleu
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267109 Such as 2-tert-butyl-4-n-octylamino-6-pyrid-2-yl-1,3,5-triazine; for treating or preventing biofilms on human tooth surfaces and oral mucosa
12/01/2005US20050267108 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005US20050267097 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
12/01/2005US20050267089 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267044 Novel compounds and compositions as cathepsin S inhibitors
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005CA2567506A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005CA2567483A1 Pyrazinylmethyl lactam derivatives
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566937A1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/01/2005CA2566610A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005CA2566466A1 Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
12/01/2005CA2566074A1 Azinyl imidazoazine and azinyl carboxamide
12/01/2005CA2565200A1 Raf modulators and methods of use
12/01/2005CA2562315A1 2-substituted pyrimidines and their use as pesticides
11/2005
11/30/2005EP1600447A1 Butyrylcholinesterase selective inhibitors
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1600180A2 Antiproliferative drug and delivery device
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599467A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/30/2005EP1599466A2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
11/30/2005EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
11/30/2005EP1599463A1 Cyano anthranilamide insecticides
11/30/2005EP1599462A2 Process of preparing imatinib
11/30/2005EP1599451A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
11/30/2005EP1599447A1 Ligands that modulate lxr-type receptors
11/30/2005EP1599440A2 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
11/30/2005EP1599167A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/30/2005EP1599096A2 Hetero substitued sodium channel blockers
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005EP1483246B1 5-substituted-alkylaminopyrazole derivatives as pesticides
11/30/2005EP1465892A4 Glycinamides as factor xa inhibitors
11/30/2005EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
11/30/2005EP1259485B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703411A Piperidine derivatives as CCR5 inhibitors
11/30/2005CN1703410A Isoquinoline compounds and medicinal use thereof
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703402A Pyridine derivatives as CB2 receptor modulators
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1703221A 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity
11/30/2005CN1703220A Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
11/30/2005CN1702069A Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702065A Fluorene-based compound and organic electroluminescent display device using the same
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229374C Substituted bisindolylmaleimides for inhibition of cell proliferation
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229354C Acyl mercapto-triazolyl derivative and use thereof as microbiocides
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229344C Farnesyl transferase inhibitors
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229341C Method for oxidizing thioether group into sulfoxide group
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229329C Substituted amino amide salicylate with fungal killing function and its prepared intermediate thereof
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969718 17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/29/2005US6969710 Compounds
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2344108C Novel derivatives of cyclobuta-indole carboxamide, process for preparing them and pharmaceutical compositions containing them
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2099213C 4-iminoquinolines, processes for their preparation, and their use
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111030A1 Quinolone antibacterial agents
11/24/2005WO2005111028A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
1 ... 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 ... 1080